0000000000064089

AUTHOR

B. Schwierin

showing 7 related works from this author

Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry

2017

Objectives: Niemann-Pick disease type C (NP-C) is a rare inherited neurovisceral disease that should be recognised by psychiatrists as a possible underlying cause of psychiatric abnormalities. This...

AdultMalePsychosismedicine.medical_specialtyPediatricsInternationalityAdolescentDiseaseYoung Adult03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesmedicinePsychiatric abnormalitiesHumansIn patientProspective StudiesRegistriesAge of OnsetChildPsychiatryBiological PsychiatryAgedNiemann–Pick disease type Cbusiness.industryMental Disordersnutritional and metabolic diseasesNiemann-Pick Disease Type CMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthSchizophreniaChild PreschoolFemalebusinessThe World Journal of Biological Psychiatry
researchProduct

Longitudinal data from the international registry for Niemann-Pick disease type C (NPC)

2014

(0.69) years. Among 74/80 patients with available data, 10 (14%) patients had early-infantile (aged b2 years), 24 (32%) late-infantile (2 to b6 years), 24 (32%) juvenile (6 to b15 years), and 16 (22%) adolescent/ adult (≥15 years) onset of neurological manifestations. Mean (95%CI) composite disability scores at enrolment and last follow-up visit were 0.39 (0.34, 0.45; N = 75) and 0.45 (0.39, 0.51; N = 76), respectively. A total of 52/72 (72%) patients were categorised as ’improved/stable’ ;2 0/ 72 (28%) were categorised as ‘progressed’. Safety and tolerability findings for miglustat were in line with previous published data. A low proportion of patients had chronic diarrhoea during follow u…

Pediatricsmedicine.medical_specialtyNiemann–Pick disease type CLongitudinal databusiness.industryEndocrinology Diabetes and MetabolismChronic diarrhoeamedicine.diseaseBiochemistryEndocrinologyTolerabilityMiglustatGeneticsMedicinebusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct

Baseline data from a prospective international disease registry for Niemann-Pick disease type C

2011

medicine.medical_specialtyNiemann–Pick disease type Cbusiness.industryEndocrinology Diabetes and MetabolismBaseline datamedicine.diseaseBiochemistryEndocrinologyDisease registryInternal medicineGeneticsmedicinebusinessMolecular BiologyMolecular Genetics and Metabolism
researchProduct

Correction: Disease and patient characteristics in NP-C patients: findings from an international disease registry

2013

International audience

Medicine(all)medicine.medical_specialty[SDV.GEN]Life Sciences [q-bio]/Geneticsbusiness.industryCorrectionPatient characteristicsGeneral MedicineDisease[SDV.GEN] Life Sciences [q-bio]/GeneticsDisease registryInternal medicinemedicineGenetics(clinical)Pharmacology (medical)businessGenetics (clinical)ComputingMilieux_MISCELLANEOUS
researchProduct

Update From the International Registry for Niemann-Pick Disease Type C (NP-C) in Clinical Practice

2012

Clinical PracticePediatricsmedicine.medical_specialtyEndocrinologyNiemann–Pick disease type Cbusiness.industryEndocrinology Diabetes and MetabolismGeneticsmedicinemedicine.diseasebusinessMolecular BiologyBiochemistryMolecular Genetics and Metabolism
researchProduct

Disease and patient characteristics in NP-C patients: findings from an international disease registry.

2013

Abstract Background Niemann-Pick disease type C (NP-C) is a rare neurovisceral disease characterized by progressive neurodegeneration and premature death. We report data recorded at enrolment in an ongoing international NP-C registry initiated in September 2009 to describe disease natural history, clinical course and treatment experience of NP-C patients in clinical practice settings. Methods The NPC Registry is a prospective observational cohort study. Participating sites are encouraged to evaluate all consecutive patients with a confirmed diagnosis of NP-C, regardless of their treatment status. All patients undergo clinical assessments and medical care as determined by their physicians. D…

MalePediatricslcsh:Medicine[SDV.GEN] Life Sciences [q-bio]/Genetics0302 clinical medicineMiglustatDiagnosisGenetics(clinical)Pharmacology (medical)Prospective StudiesRegistriesAge of OnsetEnzyme InhibitorsChildProspective cohort studyGenetics (clinical)Medicine(all)0303 health sciencesCholestasisNiemann-Pick disease type CNiemann-Pick Disease Type CGeneral MedicineDysphagia3. Good healthChild PreschoolCohortNeurologicalFemalemedicine.symptomCohort studymedicine.drugHepatomegalymedicine.medical_specialty1-DeoxynojirimycinAtaxiaAdolescent03 medical and health sciencesDisease registrymedicineHumansDisabled PersonsVertical supranuclear palsy030304 developmental biology[SDV.GEN]Life Sciences [q-bio]/Geneticsbusiness.industryResearchlcsh:RInfantMutationSymptomsSplenomegalyAge of onsetbusiness030217 neurology & neurosurgery
researchProduct

1035 The International Registry for Niemann-Pick Disease Type C (NP-C) in Clinical Practice

2012

Background and Aim An international disease registry was started in September 2009 to evaluate the long-term disease course of NP-C in clinical settings. Methods Descriptive data from enrolment are presented for all patients with available data who were included in the Registry as of 19 th August 2011. Results 121 patients have been enrolled. The median (range) age at enrolment was 16.9 (0.9−56.6) years, age at onset of neurological manifestations was 8.2 ( Conclusions Over two-thirds of this NP-C cohort had infantile or juvenile onset of neurological manifestations; neonatal jaundice was observed more frequently in these patients versus adolescent/adult-onset patients.

Pediatricsmedicine.medical_specialtyNiemann–Pick disease type Cbusiness.industryClinical settingsJaundicemedicine.diseaseDisease courseClinical PracticeJuvenile onsetDisease registryPediatrics Perinatology and Child HealthCohortmedicinemedicine.symptombusinessArchives of Disease in Childhood
researchProduct